Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis

Lignende værker

• Orthotopic bladder cancer preclinical models: Comprehensive review and technique optimization
  af: Timothy Hanlon, et al.
  Udgivet: (2025-12-01)
• PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
  af: Kasia M. Dillon, et al.
  Udgivet: (2022-06-01)
• A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs
  af: Nicole A. Wilski, et al.
  Udgivet: (2025-07-01)
• Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis
  af: Umesh Kathad, et al.
  Udgivet: (2024-01-01)
• Mutasynthesis of C17- and C21-Substituted Ansamitocins for Use as ADC Payloads
  af: Anna E. Stanley-Smith, et al.
  Udgivet: (2025-09-01)